CCS
LAB icon

Crosspoint Capital Strategies’s Standard BioTools LAB Stock Holding History

Crosspoint Capital Strategies’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-676
Closed -$16K – 840
2015
Q2 		$16K Buy
+676
New +$21.3K ﹤0.01% 447
2015
Q1 		– Sell
-338
Closed -$11K – 640
2014
Q4 		$11K Buy
+338
New +$9.57K ﹤0.01% 515
2014
Q2 		– Sell
-130,029
Closed -$5.73M – 575
2014
Q1 		$5.73M Buy
130,029
+1,046
+0.8% +$46K 2.32% 9
2013
Q4 		$6.15M Buy
+128,983
New +$3.8M 2.05% 11

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return